![]() |
|
|
CSIRO Health Sciences and Nutrition, Adelaide, SA 5000, Australia
1To whom correspondence should be addressed at P.O. Box 10041. E-mail: graeme.mcintosh{at}hsn.csiro.au
Processed wheat aleurone flour (WAF) is a source of insoluble
fermentable dietary fiber that comes from the outer layers of the wheat
kernel. A study was designed to evaluate WAF, wheat bran (WB) and
-cellulose as the source of dietary fiber (5 g/100 g of diet) in a
semipurified high fat (20 g/100 g of as 1:1 lard/sunflower seed oil)
diet fed to male Sprague-Dawley rats in which intestinal tumors
were induced using azoxymethane (AOM). WAF at 33 g/100 g of diet
(WAF33) and WB at 16 g/100 g of diet (WB16) increased the weight of
feces and produced significantly higher concentrations in the cecum of
the short-chain fatty acid butyrate (P < 0.001) than did no fiber (NF) and WAF added at only 10 g/100 g (1.5 g
of dietary fiber) (WAF10). Cecal and fecal pH were both significantly
lower in the WAF33 and WB16 treatments relative to control and no fiber
treatments (P < 0.001). The intestinal tumors in
the rats were assessed at 6 mo after the study began, and the WAF33- or
WB16-fed rats showed a trend (P = 0.06) with 43%
fewer colon adenomas relative to control. There was a significant
inverse relationship between ß-glucuronidase activity and colon
adenomas in the rat colon (r2 = 0.37, P = 0.001). WAF fiber influenced some
metabolic markers of fermentation in the colon in a manner similar to
that of WB, which, independent of the bulking effect, was associated
with a trend to reduced colon adenomas. Significantly increased cecal
ß-glucuronidase activity and/or butyrate concentrations may have
protective influences in this context by mechanisms not yet fully
elucidated.
KEY WORDS: azoxymethane colon tumors wheat aleurone flour ß-glucuronidase rats
This article has been cited by other articles:
![]() |
R. H. Dashwood, M. C. Myzak, and E. Ho Dietary HDAC inhibitors: time to rethink weak ligands in cancer chemoprevention? Carcinogenesis, February 1, 2006; 27(2): 344 - 349. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. B. Knudsen, A. Serena, A. K. B. Kjaer, H. Jorgensen, and R. Engberg Rye Bread Enhances the Production and Plasma Concentration of Butyrate but Not the Plasma Concentrations of Glucose and Insulin in Pigs J. Nutr., July 1, 2005; 135(7): 1696 - 1704. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L. Pool-Zobel, V. Selvaraju, J. Sauer, T. Kautenburger, J. Kiefer, K. K. Richter, M. Soom, and S. Wolfl Butyrate may enhance toxicological defence in primary, adenoma and tumor human colon cells by favourably modulating expression of glutathione S-transferases genes, an approach in nutrigenomics Carcinogenesis, June 1, 2005; 26(6): 1064 - 1076. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zeng and M. Briske-Anderson Prolonged Butyrate Treatment Inhibits the Migration and Invasion Potential of HT1080 Tumor Cells J. Nutr., February 1, 2005; 135(2): 291 - 295. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. N. Ebert, A. Klinder, W. H.M. Peters, A. Schaferhenrich, W. Sendt, J. Scheele, and B. L. Pool-Zobel Expression of glutathione S-transferases (GSTs) in human colon cells and inducibility of GSTM2 by butyrate Carcinogenesis, October 1, 2003; 24(10): 1637 - 1644. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Verghese, D. R. Rao, C. B. Chawan, and L. Shackelford Dietary Inulin Suppresses Azoxymethane-Induced Preneoplastic Aberrant Crypt Foci in Mature Fisher 344 Rats J. Nutr., September 1, 2002; 132(9): 2804 - 2808. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Coleman, E. K. Landstrom, P. J. Royle, A. R. Bird, and G. H. McIntosh A Diet Containing {alpha}-Cellulose and Fish Oil Reduces Aberrant Crypt Foci Formation and Modulates Other Possible Markers for Colon Cancer Risk in Azoxymethane-Treated Rats J. Nutr., August 1, 2002; 132(8): 2312 - 2318. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Emenaker, G. M. Calaf, D. Cox, M. D. Basson, and N. Qureshi Short-Chain Fatty Acids Inhibit Invasive Human Colon Cancer by Modulating uPA, TIMP-1, TIMP-2, Mutant p53, Bcl-2, Bax, p21 and PCNA Protein Expression in an In Vitro Cell Culture Model J. Nutr., November 1, 2001; 131(11): 3041S - 3046. [Abstract] [Full Text] [PDF] |
||||